Current Pharmaceutical Design
Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Contents
Current Pharmaceutical Design , Volume 19 - Number 12
Molecular Modeling and Virtual Screening of DNA Methyltransferase Inhibitors
, 19(12): 2138 - 2147Jose L. Medina-Franco and Jakyung Yoo
DOI: 10.2174/1381612811319120002
Desirability-based Multi-criteria Virtual Screening of Selective Antimicrobial Cyclic β-Hairpin Cationic Peptidomimetics
, 19(12): 2148 - 2163Maykel Cruz-Monteagudo, Yansy Romero, M. Natalia D.S. Cordeiro and Fernanda Borges
DOI: 10.2174/1381612811319120003
FDA-approved Drugs Selected Using Virtual Screening Bind Specifically to G-quadruplex DNA
, 19(12): 2164 - 2173Daimel Castillo-Gonzalez, Gisselle Perez-Machado, Aurore Guedin, Jean-Louis Mergny and Miguel-Angel Cabrera-Perez
DOI: 10.2174/1381612811319120004
Scoring Functions for Prediction of Protein-Ligand Interactions
, 19(12): 2174 - 2182Jui-Chih Wang and Jung-Hsin Lin
DOI: 10.2174/1381612811319120005
Macromolecular Structure Comparison and Docking: An Algorithmic Review
, 19(12): 2183 - 2193Eric Paquet and Herna L. Viktor
DOI: 10.2174/1381612811319120006
Modeling of 2-Pyridin-3-yl-Benzo[d][1,3]Oxazin-4-one Derivatives by Several Conformational Searching Tools and Molecular Docking
, 19(12): 2194 - 2203Mohammad Goodarzi, Alina Bora, Ana Borota, Simona Funar-Timofei, Sorin Avram and Yvan Vander Heyden
DOI: 10.2174/1381612811319120007
Mapping Myeloperoxidase to Identify its Promiscuity Properties Using Docking and Molecular Dynamics Simulations
, 19(12): 2204 - 2215LA Ramirez-Duran, MC Rosales-Hernandez, Maricarmen Hernandez-Rodriguez, Jessica Elena Mendieta-Wejebe, Jose Trujillo-Ferrara and Jose Correa-Basurto
DOI: 10.2174/1381612811319120008
Computational Approaches for Ligand Discovery and Design in Class-A G Protein- Coupled Receptors
, 19(12): 2216 - 2236David Rodriguez and Hugo Gutierrez-de-Teran
DOI: 10.2174/1381612811319120009
Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN
, 19(12): 2237 - 2244Omar Deeb, Sana Jawabreh and Mohammad Goodarzi
DOI: 10.2174/1381612811319120010
Rational Drug Design: The Search for Ras Protein Hydrolysis Intermediate Conformation Inhibitors with Both Affinity and Specificity
, 19(12): 2246 - 2258Xiliang Zheng, Zuojia Liu, Dan Li, Erkang Wang and Jin Wang
DOI: 10.2174/1381612811319120012
Selective Induction of Apoptosis: Promising Therapy in Pancreatic Cancer
, 19(12): 2259 - 2268Zuojia Liu, Dan Li, Xiliang Zheng, Erkang Wang and Jin Wang
DOI: 10.2174/1381612811319120013
Role of Bivalent Cations in Structural Stabilities of New Drug Targets ——Vacciniarelated Kinases (VRK) from Molecular Dynamics Simulations
, 19(12): 2269 - 2281Ting Fu, Hong Ren, Jiajing Zhang, Pengyu Ren, Istvan Enyedy and Guohui Li
DOI: 10.2174/1381612811319120014
The Challenge to the Rule of Homology Modeling: Folding Mechanism Study of Protein GA and GB with High Sequence Identity but Different Native Structures
, 19(12): 2282 - 2292Xue Wu, Zhong Jin, Zhilong Xiu and Guohui Li
DOI: 10.2174/1381612811319120015
Binding Free Energy Estimation for Protein-Ligand Complex Based on MM-PBSA with Various Partial Charge Models
, 19(12): 2293 - 2307Ting Fu, Zhong Jin, Zhilong Xiu and Guohui Li
DOI: 10.2174/1381612811319120016
Exploring the Relationship between Sequences, Structures, Dynamical Behaviors and Functions of New Type Protein Drugs: DARPins
, 19(12): 2308 - 2317Xue Wu, Yue Shi, Pengyu Ren, Deping Wang and Guohui Li
DOI: 10.2174/1381612811319120017
Targeting the Nuclear Transport Machinery by Rational Drug Design
, 19(12): 2318 - 2325Lei Mao and Yongliang Yang
DOI: 10.2174/1381612811319120018
Binding Site Detection and Druggability Prediction of Protein Targets for Structure- Based Drug Design
, 19(12): 2326 - 2333Yaxia Yuan, Jianfeng Pei and Luhua Lai
DOI: 10.2174/1381612811319120019
Editor-in-Chief
Alessandro Antonelli
(14789 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
(14789 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
Biography
Biography of Alessandro Antonelli
Alessandro Antonelli (Professor of Internal Medicine, MD) is Director of the Immuno-Endocrine
Section of Internal Medicine, and Head of the Laboratory of Primary Human Cells, University of
Pisa. His principal areas of expertise are autoimmune thyroid disorders, type 1 diabetes, systemic
autoimmune disorders, chemokines and cytokines, HCV-associated thyroid disorders and thyroid
cancer. His researches have been published in more than 370 articles on International journals
(Impact Factor > 1600; HI=75). He serves as an editorial board member and is Referee and
Reviewer of many scientific International journals.
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net